A rating of 76 puts Candel Therapeutics Inc (CADL) near the top of the Biotechnology industry according to InvestorsObserver. Candel Therapeutics Inc's score of 76 means it scores higher than 76% of stocks in the industry. Candel Therapeutics Inc also received an overall rating of 65, putting it above 65% of all stocks. Biotechnology is ranked 19 out of the 148 industries.
CADL has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CADL!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Candel Therapeutics Inc Stock Today?
Candel Therapeutics Inc (CADL) stock is trading at $1.59 as of 1:24 PM on Thursday, Mar 28, a gain of $0.05, or 3.25% from the previous closing price of $1.54. The stock has traded between $1.53 and $1.59 so far today. Volume today is light. So far 14,749 shares have traded compared to average volume of 68,573 shares.
Click Here to get the full Stock Report for Candel Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
